Teva Pharmaceuticals' (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results
Categories
pharmaceuticals
CVS Health (NYSE: CVS) Q1 2020 Earnings Call Transcript
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q1 2020 Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo -- Head of Investor Relations Ludwig Hantson -- Chief Executive
Alexion Pharmaceuticals (ALXN) Q1 profit drops 5% but beats estimates
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens.
Alexion (ALXN) to acquire Portola (PTLA) for $1.44 billion
Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an initial consideration
COVID-19 favors AbbVie (ABBV) in reporting upbeat Q1 results
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results
PetMed Express Inc (NASDAQ: PETS) Q4 2019 Earnings Call Transcript
PetMed Express Inc (PETS) Q4 2019 earnings call dated May. 04, 2020 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer Menderes
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the
A visual dashboard of AbbVie’s Q1 2020 earnings results
AbbVie (NYSE: ABBV) reported its first quarter 2020 earnings results, which surpassed the market's views. Adjusted EPS of $2.42 and revenue of
A visual dashboard of Amgen’s (AMGN) Q1 2020 earnings results
Amgen's (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts' estimates. The biotech firm's adjusted earnings per
Infographic: Highlights of Gilead Sciences (GILD) Q1 2020 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the
Infographic: Highlights of Abiomed (ABMD) Q4 2020 earnings report
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld
Vertex Pharmaceuticals (VRTX) reports Q1 2020 earnings results
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter
What to expect from Vertex Pharmaceuticals (VRTX) Q1 2020 earnings?
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Pfizer (NYSE: PFE) Q1 2020 Earnings Call Transcript
Pfizer Inc. (PFE) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman and
Merck & Co (NYSE: MRK) Q1 2020 Earnings Call Transcript
Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS
A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts' forecast. Earnings, on an
Eli Lilly (LLY) reports Q1 2020 earnings results
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company
Johnson & Johnson mentioned COVID 80 times during earnings call, vs. Abbott’s 16
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1 2020 last week. Despite
Biofrontera AG (NASDAQ: BFRA) Q4 2019 Earnings Call Transcript
Biofrontera AG (BFRA) Q4 2019 earnings call dated Apr. 21, 2020 Corporate Participants: Pamela Keck -- Investor Relations Hermann Lubbert -- Chief Executive Officer Thomas Schaffer -- Chief